The Vaccines Council approved the framework for providing preliminary Covid 66 vaccine for 18 million people, including 3 groups, namely 608 medical personnel and the VHV. Waiting to see more information. Need to inject 1 or 2 injections. Which formula do you use? may add some more groups with approval Local governments jointly procure vaccines to increase the budget for health promotion but must not be redundant
On November 10, Dr. Opas Karnkawinpong Permanent Secretary, Ministry of Public Health (MoPH) gave an interview after the 2nd meeting of the National Vaccine Committee, that in the past, we vaccinated 143 million doses of Covid-19 vaccine. It was found that it was effective and saved the lives of Thai people at least 5 hundred thousand people. Therefore, the meeting agreed on the principle of the framework guidelines for the provision of the COVID-19 vaccine year 2023, but because academic information from the main agencies such as the World Health Organization (WHO) has not yet come out on how many injections are needed. because academic information is insufficient Therefore, we adhere to the framework according to the influenza vaccine, which is 1-2 injections per year in 3 groups: 1. Group 608 is the elderly and patients with chronic diseases. which is a risk group for death 2. Medical personnel and front line officers and 3. Volunteers. A total of about 18 million people, if 1 dose, 18 million doses, 2 doses, 36 million doses, by handing the relevant agencies to further planning.
“This is a rough frame. But how much is the exact number? If there is more information, it will be considered. As for whether it is a vaccine, any formula must look at academic information. Because vaccine information is always changing. Now that there is a new vaccine I’m still alone Because it’s not very different from the old one. And it’s much more expensive than before. Waiting for as much information as possible Make sure and get the most value. As for other groups, how to add more must follow the information first, since it is not a dangerous contagious disease. back to normal The budget must be used as usual. Whichever has a budget, use it. No, spend money outside the budget. or which one is urgently needed and has no money, use the central budget according to the steps It is the duty of the Department of Disease Control to procure it,” said Dr. Opas.
Dr. Opas said Another issue is the approval of the principle that the local government organization (DOT) can jointly purchase and procure vaccines. to help enhance vaccination Because we see the same problem that some agencies, such as the Bangkok Metropolitan Administration, took the budget to provide vaccines. This is a good part of increasing the budget for health promotion and disease prevention of the country by using budgets from other sources. But it must be appropriate. By the meeting, be careful of the duplication of the budget because it will be the budget of the local government or various regular budgets. is the state budget by giving the National Vaccine Institute to discuss the relevant procedures because it must regulate both the suitability, worthiness, and procurement according to the specified criteria Supply according to the standard And must not overlap, which the local authorities with a lot of money may be injected Less money may not be injected, then go look at the details.
Dr. Opas said that in addition, the meeting also acknowledged the progress of research and development of the COVID-19 vaccine, which many agencies in Thailand have advanced. Even if not registered But please continue to continue Because in the future, there may be many more doses of the covid vaccine. to rely on the production potential of Thailand itself Agencies involved in vaccine research and development include states such as universities such as Chulalongkorn University, or the Pharmaceutical Organization of Biotech, while the private sector has Bionet Asia. Siam Biosciences, etc., is a network for further development of the COVID vaccine, including other vaccines.
Dr. Nakhon Premsri, director of the National Institute of Vaccines, said that although COVID-19 vaccine research in the country is not fast, but progress has been made. The meeting agreed that it should continue. will be able to obtain a registered vaccine and is the source if the breed will continue Although we can’t do it as fast as other countries.